Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mays Shawawrah

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Medicine|September 10, 2024
Progressive multiple sclerosis: A bibliometric analysisMays Shawawrah, Saif Aldeen Alryalat
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 2, 2026
Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: a systematic review and meta-analysis with subgroup evaluationBara M Hammadeh, Sadeen Sameer, Mohammed Alnajjar, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 18, 2024
The cost-of-illness of multiple sclerosis in JordanIbrahim Alabbadi, Sara Al-Ajlouny, Yazan Alsoud, et al.
Journal of Bodywork and Movement Therapies|June 9, 2026
Exploring the impact of stress on balance and gait speed in people with multiple sclerosisDina Boshareh, Mohammad Al-Wardat, Khader Al Mhdawi, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 4, 2020
In-Hospital Delays for Acute Stroke Treatment Delivery During the COVID-19 PandemicAristeidis H Katsanos, Danielle de Sa Boasquevisque, Mustafa Ahmed Al-Qarni, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Medicine|September 10, 2024
Progressive multiple sclerosis: A bibliometric analysisMays Shawawrah, Saif Aldeen Alryalat
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 2, 2026
Efficacy and safety of extended-interval dosing of natalizumab in multiple sclerosis: a systematic review and meta-analysis with subgroup evaluationBara M Hammadeh, Sadeen Sameer, Mohammed Alnajjar, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|September 18, 2024
The cost-of-illness of multiple sclerosis in JordanIbrahim Alabbadi, Sara Al-Ajlouny, Yazan Alsoud, et al.
Journal of Bodywork and Movement Therapies|June 9, 2026
Exploring the impact of stress on balance and gait speed in people with multiple sclerosisDina Boshareh, Mohammad Al-Wardat, Khader Al Mhdawi, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 4, 2020
In-Hospital Delays for Acute Stroke Treatment Delivery During the COVID-19 PandemicAristeidis H Katsanos, Danielle de Sa Boasquevisque, Mustafa Ahmed Al-Qarni, et al.
Pageof 1